Your trusted destination for CME, CPD & Medical Education across the Middle East.
The International Conference on Medicinal Chemistry and Nanomedicine Applications (ICMCNAA-26) is a premier hybrid event in Riyadh, bringing together global experts to explore the latest advancements in drug delivery, molecular modeling, and therapeutic innovations.
The International Conference on Medicinal Chemistry and Nanomedicine Applications (ICMCNAA-26) will be held in Riyadh, Saudi Arabia, offering both in-person and virtual participation. This highly anticipated event aims to provide a multidisciplinary platform for researchers, academicians, and industry professionals to disseminate their latest findings and network with global peers. The conference will feature an extensive program of paper and poster presentations, keynote speeches, and workshops focused on accelerating the adoption of innovations in medicinal chemistry and nanomedicine. Aligned with global sustainability goals (SDGs 3, 4, and 9), the event highlights critical topics such as drug delivery systems, chemical biology, and translational research, offering attendees a comprehensive outlook on the future of pharmacological therapies.
Exploring the use of nanomaterials for targeted and controlled drug release.
Innovations in delivering cytotoxic agents directly to tumor cells while sparing healthy tissue.
Strategies to improve drug penetration across the blood-brain barrier and other complex tissues.
Utilizing in silico methods to predict drug-receptor interactions and optimize lead compounds.
Analyzing how chemical structure modifications affect biological activity and potency.
Leveraging artificial intelligence to accelerate the identification of novel therapeutic compounds.
Techniques for discovering new therapeutic targets using advanced chemical probes.
Methods for rapidly testing large libraries of compounds for specific biological activity.
Identifying molecular indicators for disease progression and treatment efficacy.
Development and clinical application of monoclonal antibodies and recombinant proteins.
Advancements in CRISPR, CAR-T cells, and other genetic interventions.
Tailoring pharmacological treatments based on individual genetic and phenotypic profiles.
Accredited by the Saudi Commission for Health Specialties (SCFHS) for 6 CME hours.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow